Global Pharma and Health Care Market Size, Share, Trends and Forecast 2022-2030

Market Analysis and Insights: Global Pharma and Health Care Market
The pharmaceutical industry, it is composed of companies developing and manufacturing innovative medicines and generic pharmaceuticals, as well as over-the-counter drug products. The sector is made up of a number of sub-sectors that service different market segments.

Health products are vitamins, minerals, herbal medicines, homeopathic preparations, probiotics and even some traditional medicines are also prescribed by doctor or any equivalent physician.

In this report, we mainly study the pharma and healthcare product.

The global Pharma and Health Care market size is projected to reach US$ 1644850 million by 2028, from US$ 1245880 million in 2021, at a CAGR of 4.0% during 2022-2028.

North America is the largest consumption place, with a consumption market share nearly 50%. Following North America, Asia-Pacific is the second largest consumption place with the consumption market share of 25%.

Market competition is intense. The key players are Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., etc. The top five vendors held 20% of the market share.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharma and Health Care market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharma and Health Care market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharma and Health Care market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharma and Health Care market.

Impact of Covid-19 Outbreak

This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.

Segmental Analysis

The report has been segmented into product and application segments. The researchers have documented all the products present today in the Pharma and Health Care market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.

Pharma and Health Care Breakdown Data by Format

Bottle

Blister

Others

Pharma and Health Care Breakdown Data by Prescription

OTC Drugs

Prescription Drugs

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Competitive Landscape

This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:

Johnson & Johnson

Novartis

Roche

AbbVie

Merck & Co.

Bristol Myers Squibb

GlaxoSmithKline

Pfizer

Sanofi

Takeda

AstraZeneca

Bayer

Eli Lilly & Co.

Gilead Sciences

Amgen

Novo Nordisk

Teva

Boehringer Ingelheim

Biogen

Astellas

1 Report Business Overview
1.1 Study Scope

1.2 Market Analysis by Format

1.2.1 Global Pharma and Health Care Market Size Growth Rate by Format, 2017 VS 2021 VS 2028

1.2.2 Bottle

1.2.3 Blister

1.2.4 Others

1.3 Market by Prescription

1.3.1 Global Pharma and Health Care Market Size Growth Rate by Prescription, 2017 VS 2021 VS 2028

1.3.2 OTC Drugs

1.3.3 Prescription Drugs

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Pharma and Health Care Market Perspective (2017-2028)

2.2 Pharma and Health Care Growth Trends by Region

2.2.1 Pharma and Health Care Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Pharma and Health Care Historic Market Size by Region (2017-2022)

2.2.3 Pharma and Health Care Forecasted Market Size by Region (2023-2028)

2.3 Pharma and Health Care Market Dynamics

2.3.1 Pharma and Health Care Industry Trends

2.3.2 Pharma and Health Care Market Drivers

2.3.3 Pharma and Health Care Market Challenges

2.3.4 Pharma and Health Care Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pharma and Health Care Players by Revenue

3.1.1 Global Top Pharma and Health Care Players by Revenue (2017-2022)

3.1.2 Global Pharma and Health Care Revenue Market Share by Players (2017-2022)

3.2 Global Pharma and Health Care Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Pharma and Health Care Revenue

3.4 Global Pharma and Health Care Market Concentration Ratio

3.4.1 Global Pharma and Health Care Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pharma and Health Care Revenue in 2021

3.5 Pharma and Health Care Key Players Head office and Area Served

3.6 Key Players Pharma and Health Care Product Solution and Service

3.7 Date of Enter into Pharma and Health Care Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Pharma and Health Care Breakdown Data by Format

4.1 Global Pharma and Health Care Historic Market Size by Format (2017-2022)

4.2 Global Pharma and Health Care Forecasted Market Size by Format (2023-2028)

5 Pharma and Health Care Breakdown Data by Prescription

5.1 Global Pharma and Health Care Historic Market Size by Prescription (2017-2022)

5.2 Global Pharma and Health Care Forecasted Market Size by Prescription (2023-2028)

6 North America

6.1 North America Pharma and Health Care Market Size (2017-2028)

6.2 North America Pharma and Health Care Market Size by Format

6.2.1 North America Pharma and Health Care Market Size by Format (2017-2022)

6.2.2 North America Pharma and Health Care Market Size by Format (2023-2028)

6.2.3 North America Pharma and Health Care Market Share by Format (2017-2028)

6.3 North America Pharma and Health Care Market Size by Prescription

6.3.1 North America Pharma and Health Care Market Size by Prescription (2017-2022)

6.3.2 North America Pharma and Health Care Market Size by Prescription (2023-2028)

6.3.3 North America Pharma and Health Care Market Share by Prescription (2017-2028)

6.4 North America Pharma and Health Care Market Size by Country

6.4.1 North America Pharma and Health Care Market Size by Country (2017-2022)

6.4.2 North America Pharma and Health Care Market Size by Country (2023-2028)

6.4.3 United States

6.4.4 Canada

7 Europe

7.1 Europe Pharma and Health Care Market Size (2017-2028)

7.2 Europe Pharma and Health Care Market Size by Format

7.2.1 Europe Pharma and Health Care Market Size by Format (2017-2022)

7.2.2 Europe Pharma and Health Care Market Size by Format (2023-2028)

7.2.3 Europe Pharma and Health Care Market Share by Format (2017-2028)

7.3 Europe Pharma and Health Care Market Size by Prescription

7.3.1 Europe Pharma and Health Care Market Size by Prescription (2017-2022)

7.3.2 Europe Pharma and Health Care Market Size by Prescription (2023-2028)

7.3.3 Europe Pharma and Health Care Market Share by Prescription (2017-2028)

7.4 Europe Pharma and Health Care Market Size by Country

7.4.1 Europe Pharma and Health Care Market Size by Country (2017-2022)

7.4.2 Europe Pharma and Health Care Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Pharma and Health Care Market Size (2017-2028)

8.2 Asia-Pacific Pharma and Health Care Market Size by Format

8.2.1 Asia-Pacific Pharma and Health Care Market Size by Format (2017-2022)

8.2.2 Asia-Pacific Pharma and Health Care Market Size by Format (2023-2028)

8.2.3 Asia-Pacific Pharma and Health Care Market Share by Format (2017-2028)

8.3 Asia-Pacific Pharma and Health Care Market Size by Prescription

8.3.1 Asia-Pacific Pharma and Health Care Market Size by Prescription (2017-2022)

8.3.2 Asia-Pacific Pharma and Health Care Market Size by Prescription (2023-2028)

8.3.3 Asia-Pacific Pharma and Health Care Market Share by Prescription (2017-2028)

8.4 Asia-Pacific Pharma and Health Care Market Size by Region

8.4.1 Asia-Pacific Pharma and Health Care Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Pharma and Health Care Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Pharma and Health Care Market Size (2017-2028)

9.2 Latin America Pharma and Health Care Market Size by Format

9.2.1 Latin America Pharma and Health Care Market Size by Format (2017-2022)

9.2.2 Latin America Pharma and Health Care Market Size by Format (2023-2028)

9.2.3 Latin America Pharma and Health Care Market Share by Format (2017-2028)

9.3 Latin America Pharma and Health Care Market Size by Prescription

9.3.1 Latin America Pharma and Health Care Market Size by Prescription (2017-2022)

9.3.2 Latin America Pharma and Health Care Market Size by Prescription (2023-2028)

9.3.3 Latin America Pharma and Health Care Market Share by Prescription (2017-2028)

9.4 Latin America Pharma and Health Care Market Size by Country

9.4.1 Latin America Pharma and Health Care Market Size by Country (2017-2022)

9.4.2 Latin America Pharma and Health Care Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pharma and Health Care Market Size (2017-2028)

10.2 Middle East & Africa Pharma and Health Care Market Size by Format

10.2.1 Middle East & Africa Pharma and Health Care Market Size by Format (2017-2022)

10.2.2 Middle East & Africa Pharma and Health Care Market Size by Format (2023-2028)

10.2.3 Middle East & Africa Pharma and Health Care Market Share by Format (2017-2028)

10.3 Middle East & Africa Pharma and Health Care Market Size by Prescription

10.3.1 Middle East & Africa Pharma and Health Care Market Size by Prescription (2017-2022)

10.3.2 Middle East & Africa Pharma and Health Care Market Size by Prescription (2023-2028)

10.3.3 Middle East & Africa Pharma and Health Care Market Share by Prescription (2017-2028)

10.4 Middle East & Africa Pharma and Health Care Market Size by Country

10.4.1 Middle East & Africa Pharma and Health Care Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Pharma and Health Care Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 Johnson & Johnson

11.1.1 Johnson & Johnson Company Details

11.1.2 Johnson & Johnson Business Overview

11.1.3 Johnson & Johnson Pharma and Health Care Introduction

11.1.4 Johnson & Johnson Revenue in Pharma and Health Care Business (2017-2022)

11.1.5 Johnson & Johnson Recent Developments

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Pharma and Health Care Introduction

11.2.4 Novartis Revenue in Pharma and Health Care Business (2017-2022)

11.2.5 Novartis Recent Developments

11.3 Roche

11.3.1 Roche Company Details

11.3.2 Roche Business Overview

11.3.3 Roche Pharma and Health Care Introduction

11.3.4 Roche Revenue in Pharma and Health Care Business (2017-2022)

11.3.5 Roche Recent Developments

11.4 AbbVie

11.4.1 AbbVie Company Details

11.4.2 AbbVie Business Overview

11.4.3 AbbVie Pharma and Health Care Introduction

11.4.4 AbbVie Revenue in Pharma and Health Care Business (2017-2022)

11.4.5 AbbVie Recent Developments

11.5 Merck & Co.

11.5.1 Merck & Co. Company Details

11.5.2 Merck & Co. Business Overview

11.5.3 Merck & Co. Pharma and Health Care Introduction

11.5.4 Merck & Co. Revenue in Pharma and Health Care Business (2017-2022)

11.5.5 Merck & Co. Recent Developments

11.6 Bristol Myers Squibb

11.6.1 Bristol Myers Squibb Company Details

11.6.2 Bristol Myers Squibb Business Overview

11.6.3 Bristol Myers Squibb Pharma and Health Care Introduction

11.6.4 Bristol Myers Squibb Revenue in Pharma and Health Care Business (2017-2022)

11.6.5 Bristol Myers Squibb Recent Developments

11.7 GlaxoSmithKline

11.7.1 GlaxoSmithKline Company Details

11.7.2 GlaxoSmithKline Business Overview

11.7.3 GlaxoSmithKline Pharma and Health Care Introduction

11.7.4 GlaxoSmithKline Revenue in Pharma and Health Care Business (2017-2022)

11.7.5 GlaxoSmithKline Recent Developments

11.8 Pfizer

11.8.1 Pfizer Company Details

11.8.2 Pfizer Business Overview

11.8.3 Pfizer Pharma and Health Care Introduction

11.8.4 Pfizer Revenue in Pharma and Health Care Business (2017-2022)

11.8.5 Pfizer Recent Developments

11.9 Sanofi

11.9.1 Sanofi Company Details

11.9.2 Sanofi Business Overview

11.9.3 Sanofi Pharma and Health Care Introduction

11.9.4 Sanofi Revenue in Pharma and Health Care Business (2017-2022)

11.9.5 Sanofi Recent Developments

11.10 Takeda

11.10.1 Takeda Company Details

11.10.2 Takeda Business Overview

11.10.3 Takeda Pharma and Health Care Introduction

11.10.4 Takeda Revenue in Pharma and Health Care Business (2017-2022)

11.10.5 Takeda Recent Developments

11.11 AstraZeneca

11.11.1 AstraZeneca Company Details

11.11.2 AstraZeneca Business Overview

11.11.3 AstraZeneca Pharma and Health Care Introduction

11.11.4 AstraZeneca Revenue in Pharma and Health Care Business (2017-2022)

11.11.5 AstraZeneca Recent Developments

11.12 Bayer

11.12.1 Bayer Company Details

11.12.2 Bayer Business Overview

11.12.3 Bayer Pharma and Health Care Introduction

11.12.4 Bayer Revenue in Pharma and Health Care Business (2017-2022)

11.12.5 Bayer Recent Developments

11.13 Eli Lilly & Co.

11.13.1 Eli Lilly & Co. Company Details

11.13.2 Eli Lilly & Co. Business Overview

11.13.3 Eli Lilly & Co. Pharma and Health Care Introduction

11.13.4 Eli Lilly & Co. Revenue in Pharma and Health Care Business (2017-2022)

11.13.5 Eli Lilly & Co. Recent Developments

11.14 Gilead Sciences

11.14.1 Gilead Sciences Company Details

11.14.2 Gilead Sciences Business Overview

11.14.3 Gilead Sciences Pharma and Health Care Introduction

11.14.4 Gilead Sciences Revenue in Pharma and Health Care Business (2017-2022)

11.14.5 Gilead Sciences Recent Developments

11.15 Amgen

11.15.1 Amgen Company Details

11.15.2 Amgen Business Overview

11.15.3 Amgen Pharma and Health Care Introduction

11.15.4 Amgen Revenue in Pharma and Health Care Business (2017-2022)

11.15.5 Amgen Recent Developments

11.16 Novo Nordisk

11.16.1 Novo Nordisk Company Details

11.16.2 Novo Nordisk Business Overview

11.16.3 Novo Nordisk Pharma and Health Care Introduction

11.16.4 Novo Nordisk Revenue in Pharma and Health Care Business (2017-2022)

11.16.5 Novo Nordisk Recent Developments

11.17 Teva

11.17.1 Teva Company Details

11.17.2 Teva Business Overview

11.17.3 Teva Pharma and Health Care Introduction

11.17.4 Teva Revenue in Pharma and Health Care Business (2017-2022)

11.17.5 Teva Recent Developments

11.18 Boehringer Ingelheim

11.18.1 Boehringer Ingelheim Company Details

11.18.2 Boehringer Ingelheim Business Overview

11.18.3 Boehringer Ingelheim Pharma and Health Care Introduction

11.18.4 Boehringer Ingelheim Revenue in Pharma and Health Care Business (2017-2022)

11.18.5 Boehringer Ingelheim Recent Developments

11.19 Biogen

11.19.1 Biogen Company Details

11.19.2 Biogen Business Overview

11.19.3 Biogen Pharma and Health Care Introduction

11.19.4 Biogen Revenue in Pharma and Health Care Business (2017-2022)

11.19.5 Biogen Recent Developments

11.20 Astellas

11.20.1 Astellas Company Details

11.20.2 Astellas Business Overview

11.20.3 Astellas Pharma and Health Care Introduction

11.20.4 Astellas Revenue in Pharma and Health Care Business (2017-2022)

11.20.5 Astellas Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer